CovidSurg-3: Outcomes of Surgery in Covid-19 Infection (Covidsurg-3) Multicentre clinical trial, total recruited 2000 participants
(Dr. Sonali Kodange, Intensive Care, SQCCCRC)
- A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice (IMreal)
(Prof. Mansour Al Moundhri, Medical Oncology, SQCCCRC)
- A protocol for multiple phase 3 multi-centre randomised, registry, embedded, single blinded clinical trials comparing conservative oxygen therapy to liberal oxygen therapy in mechanically ventilated adults in the intensive care unit nested within a 40,000-patient mega trial (Mega-ROX) (Dr. Airton Leonardo, Intensive Care, SQCCCRC )
- Sedation practice in intensive care evaluation randomised controlled trial: SPICE IV Study
(Dr. Airton Leonardo, Intensive Care, SQCCCRC )
- REtroperitoneal SArcoma (RESAR): prospective collection of primary retroperitoneal sarcoma patient’s data, radiological and pathological material for the TransAtlantic Australasian Retroperitoneal Sarcoma Working Group
(Dr. Boris Itkin, Medical Oncology, SQCCCRC)
- Effect of Molecular Markers on Fluorouracil and Capecitabine Pharmacokinetics and Clinical Outcomes
(Ms. Bushra Mustafa, Pharmacy, SQCCCRC_
- Overcoming chemotherapy resistance in gynecological cancers using Marine Natural Product: putative role of miRNA expression
(Dr. Ikram, Medical Oncology, SQCCCRC)
- Direct sterility testing using a Closed System Transfer Device (CSTD) on biological therapy
(Ms. Maha Hassan, Pharmacy, SQCCCRC)
- Establishment of Diagnostic Reference Levels (DRLs) for Adult in Nuclear Medicine Imaging in Sultan Qaboos Comprehensive Cancer Care and Research Centre.
(Ms. Noura AL Makhmari, Radiology, SQCCCRC)
- Melanoma in Oman. (MIO) Focus on sun unexposed melanoma. Mixed cohort study.
(Dr. Boris Itkin, Medical Oncology, SQCCCRC)
- Predictive molecular biomarkers for response to neoadjuvant FLOT4 chemotherapy in locally advanced resectable gastric or gastro-esophageal junction adenocarcinoma using Multi-Omics analysis
(Prof. Mansour Al Moundhri, SQCCCRC)
- Clinical utility of molecular profiling in rare tumors in the real-world setting. Cohort study – “CLEAR”. Protocol. Version 1.0 Proposal
(Dr. Bois Itkin, Medical Oncology, SQCCCRC_)
- Patterns of Toxicity with Immune Checkpoint Inhibitors in Solid Tumors: Real-world Experience from a Tertiary Care Centre in Oman
(Mr. Nameer AlWard, Pharmacy, SQCCCRC_)